Date of Report (Date of Earliest Event Reported) | October 29, 2015 |
Delaware | 1-5353 | 23-1147939 |
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (IRS Employer Identification No.) |
550 East Swedesford Road, Suite 400, Wayne, Pennsylvania | 19087 | |
(Address of Principal Executive Offices) | (Zip Code) | |
Registrant’s Telephone Number, Including Area Code | (610) 225-6800 |
Not applicable |
(Former Name or Former Address, If Changed Since Last Report) |
Date: October 29, 2015 | TELEFLEX INCORPORATED By: /s/ Thomas E. Powell Name: Thomas E. Powell Title: Executive Vice President and Chief Financial Officer |
Exhibit No. | Description | |
99.1 | Earnings Press Release, dated October 29, 2015 | |
99.2 | Earnings Conference Call Slide Presentation |
Three Months Ended | % Increase/ (Decrease) | |||||||||||||
September 27, 2015 | September 28, 2014 | Constant Currency | Foreign Currency | Total Change | ||||||||||
(Dollars in millions) | ||||||||||||||
Vascular North America | $ | 82.6 | $ | 76.7 | 8.6 | % | (0.8 | %) | 7.8 | % | ||||
Surgical North America | 39.6 | 36.1 | 11.1 | % | (1.5 | %) | 9.6 | % | ||||||
Anesthesia North America | 47.6 | 47.2 | 1.6 | % | (0.7 | %) | 0.9 | % | ||||||
EMEA | 120.9 | 141.2 | 1.1 | % | (15.5 | %) | (14.4 | %) | ||||||
Asia | 61.9 | 62.0 | 11.3 | % | (11.5 | %) | (0.2 | %) | ||||||
OEM | 39.0 | 39.2 | 2.5 | % | (3.1 | %) | (0.6 | %) | ||||||
All Other | 52.1 | 54.8 | (2.7 | %) | (2.3 | %) | (5.0 | %) | ||||||
Total | $ | 443.7 | $ | 457.2 | 4.2 | % | (7.1 | %) | (2.9 | %) |
Low | High | |||
Forecasted 2015 GAAP revenue growth | (2.3 | %) | (1.5 | %) |
Estimated impact of foreign currency fluctuations | 7.0 | % | 7.0 | % |
Forecasted 2015 constant currency revenue growth | 4.7 | % | 5.5 | % |
Low | High | |||||
Diluted earnings per share attributable to common shareholders | $4.53 | $4.63 | ||||
Restructuring, impairment charges and special items, net of tax | $0.60 | $0.60 | ||||
Intangible amortization expense, net of tax | $0.90 | $0.90 | ||||
Amortization of debt discount on convertible notes, net of tax | $0.17 | $0.17 | ||||
Adjusted diluted earnings per share | $6.20 | $6.30 |
Quarter Ended – September 27, 2015 | |||||||||||||||||||||||||||||
Cost of goods sold | Selling, general and administrative expenses | Research and development expenses | Restructuring and other impairment charges | (Gain) loss on sale of business and assets | Interest expense, net | Income taxes | Net income (loss) attributable to common shareholders from continuing operations | Diluted earnings per share available to common shareholders | Shares used in calculation of GAAP and adjusted earnings per share | ||||||||||||||||||||
GAAP Basis | $215.5 | $138.8 | $12.6 | $0.7 | ($0.4 | ) | $14.2 | $0.8 | $61.5 | $1.27 | 48,532 | ||||||||||||||||||
Adjustments | |||||||||||||||||||||||||||||
Restructuring and other impairment charges | — | — | — | 0.7 | — | — | 0.3 | 0.4 | $0.01 | — | |||||||||||||||||||
Losses and other charges (A) | 2.3 | (0.5) | — | — | (0.4) | — | 0.8 | 0.6 | $0.01 | — | |||||||||||||||||||
Amortization of debt discount on convertible notes | — | — | — | — | — | 3.3 | 1.2 | 2.1 | $0.04 | — | |||||||||||||||||||
Intangible amortization expense | — | 15.5 | — | — | — | — | 4.1 | 11.4 | $0.23 | — | |||||||||||||||||||
Tax adjustment (B) | — | — | — | — | — | — | 3.9 | (3.9) | ($0.08 | ) | — | ||||||||||||||||||
Shares due to Teleflex under note hedge (C) | — | — | — | — | — | — | — | — | $0.11 | (3,536) | |||||||||||||||||||
Adjusted basis | $213.2 | $123.9 | $12.6 | — | — | $10.8 | $11.1 | $72.1 | $1.60 | 44,996 | |||||||||||||||||||
Quarter Ended – September 28, 2014 | |||||||||||||||||||||||||||||
Cost of goods sold | Selling, general and administrative expenses | Research and development expenses | Restructuring and other impairment charges | (Gain) loss on sale of business and assets | Interest expense, net | Income taxes | Net income (loss) attributable to common shareholders from continuing operations | Diluted earnings per share available to common shareholders | Shares used in calculation of GAAP and adjusted earnings per share | ||||||||||||||||||||
GAAP Basis | $221.0 | $138.3 | $14.9 | $1.1 | — | $17.0 | $9.7 | $55.1 | $1.18 | 46,628 | |||||||||||||||||||
Adjustments | |||||||||||||||||||||||||||||
Restructuring and other impairment charges | — | — | — | 1.1 | — | — | 0.1 | 1.0 | $0.02 | — | |||||||||||||||||||
Losses and other charges (A) | 1.9 | (0.9) | 0.0 | — | — | — | 1.1 | (0.0) | — | — | |||||||||||||||||||
Amortization of debt discount on convertible notes | — | — | — | — | — | 3.1 | 1.1 | 2.0 | $0.04 | — | |||||||||||||||||||
Intangible amortization expense | — | 15.0 | — | — | — | — | 4.0 | 11.0 | $0.24 | — | |||||||||||||||||||
Shares due to Teleflex under note hedge (C) | — | — | — | — | — | — | — | — | $0.09 | (2,799) | |||||||||||||||||||
Adjusted basis | $219.1 | $124.2 | $14.8 | — | — | $13.9 | $16.0 | $69.0 | $1.57 | 43,829 |
Year-to-date Ended – September 27, 2015 | ||||||||||||||||||||||||||||||||
Cost of goods sold | Selling, general and administrative expenses | Research and development expenses | Restructuring and other impairment charges | (Gain) loss on sale of business and assets | Interest expense, net | Loss on extinguishment of debt, net | Income taxes | Net income (loss) attributable to common shareholders from continuing operations | Diluted earnings per share available to common shareholders | Shares used in calculation of GAAP and adjusted earnings per share | ||||||||||||||||||||||
GAAP Basis | $641.1 | $420.8 | $38.9 | $5.7 | ($0.4 | ) | $47.2 | $10.5 | $15.4 | $145.4 | $3.03 | 47,969 | ||||||||||||||||||||
Adjustments: | ||||||||||||||||||||||||||||||||
Restructuring and other impairment charges | — | — | — | 5.7 | — | — | — | 2.1 | 3.6 | $0.08 | — | |||||||||||||||||||||
Losses and other charges (A) | 7.6 | (3.0) | — | — | (0.4) | — | — | 2.2 | 1.9 | $0.03 | — | |||||||||||||||||||||
Amortization of debt discount on convertible notes | — | — | — | — | — | 9.8 | — | 3.6 | 6.2 | $0.13 | — | |||||||||||||||||||||
Intangible amortization expense | — | 45.3 | — | — | — | — | — | 12.0 | 33.3 | $0.69 | — | |||||||||||||||||||||
Loss on extinguishment of debt, net | — | — | — | — | — | — | 10.5 | 3.8 | 6.6 | $0.14 | — | |||||||||||||||||||||
Tax adjustment (B) | — | — | — | — | — | — | — | 4.1 | (4.1) | ($0.08 | ) | — | ||||||||||||||||||||
Shares due to Teleflex under note hedge (C) | — | — | — | — | — | — | — | — | — | $0.30 | (3,319) | |||||||||||||||||||||
Adjusted basis | $633.5 | $378.5 | $38.9 | — | — | $37.4 | — | $43.1 | $193.0 | $4.32 | 44,650 | |||||||||||||||||||||
Year-to-date Ended – September 28, 2014 | ||||||||||||||||||||||||||||||||
Cost of goods sold | Selling, general and administrative expenses | Research and development expenses | Restructuring and other impairment charges | (Gain) loss on sale of business and assets | Interest expense, net | Loss on extinguishment of debt, net | Income taxes | Net income (loss) attributable to common shareholders from continuing operations | Diluted earnings per share available to common shareholders | Shares used in calculation of GAAP and adjusted earnings per share | ||||||||||||||||||||||
GAAP Basis | $662.4 | $425.4 | $43.8 | $16.5 | — | $48.2 | — | $28.2 | $138.6 | $3.00 | 46,256 | |||||||||||||||||||||
Adjustments: | ||||||||||||||||||||||||||||||||
Restructuring and other impairment charges | — | — | — | 16.5 | — | — | — | 4.7 | 11.8 | $0.26 | — | |||||||||||||||||||||
Losses and other charges (A) | 2.8 | (2.1) | 0.1 | — | — | — | — | 1.9 | (1.1) | ($0.02) | — | |||||||||||||||||||||
Amortization of debt discount on convertible notes | — | — | — | — | — | 9.1 | — | 3.3 | 5.8 | $0.12 | — | |||||||||||||||||||||
Intangible amortization expense | — | 47.1 | — | — | — | — | — | 13.9 | 33.1 | $0.72 | — | |||||||||||||||||||||
Loss on extinguishment of debt, net | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||
Tax adjustment (B) | — | — | — | — | — | — | — | 0.2 | (0.2 | ) | ($0.01) | — | ||||||||||||||||||||
Shares due to Teleflex under note hedge (C) | — | — | — | — | — | — | — | — | — | $0.25 | (2,654) | |||||||||||||||||||||
Adjusted basis | $659.6 | $380.4 | $43.7 | — | — | $39.1 | — | $52.3 | $187.9 | $4.31 | 43,602 |
September 27, 2015 | December 31, 2014 |
(Dollars in thousands) | ||||||||
Note payable and current portion of long term borrowings | $ | 416,685 | $ | 368,401 | ||||
Long term borrowings | 646,000 | 700,000 | ||||||
Unamortized debt discount | 26,386 | 36,197 | ||||||
Total debt obligations | 1,089,071 | 1,104,598 | ||||||
Less: cash and cash equivalents | 276,463 | 303,236 | ||||||
Net debt obligations | $ | 812,608 | $ | 801,362 | ||||
Three Months Ended | Nine Months Ended | ||||||||||||||
September 27, 2015 | September 28, 2014 | September 27, 2015 | September 28, 2014 | ||||||||||||
(Dollars and shares in thousands, except per share) | |||||||||||||||
Net revenues | $ | 443,714 | $ | 457,173 | $ | 1,325,189 | $ | 1,363,824 | |||||||
Cost of goods sold | 215,501 | 221,007 | 641,102 | 662,411 | |||||||||||
Gross profit | 228,213 | 236,166 | 684,087 | 701,413 | |||||||||||
Selling, general and administrative expenses | 138,840 | 138,252 | 420,765 | 425,392 | |||||||||||
Research and development expenses | 12,571 | 14,871 | 38,898 | 43,803 | |||||||||||
Restructuring charges | 660 | 1,108 | 5,688 | 16,511 | |||||||||||
Gain on sale of assets | (408 | ) | — | (408 | ) | — | |||||||||
Income from continuing operations before interest, extinguishment of debt and taxes | 76,550 | 81,935 | 219,144 | 215,707 | |||||||||||
Interest expense | 14,306 | 17,184 | 47,685 | 48,650 | |||||||||||
Interest income | (130 | ) | (161 | ) | (453 | ) | (494 | ) | |||||||
Loss on extinguishment of debt | — | — | 10,454 | — | |||||||||||
Income from continuing operations before taxes | 62,374 | 64,912 | 161,458 | 167,551 | |||||||||||
Taxes on income from continuing operations | 803 | 9,684 | 15,415 | 28,224 | |||||||||||
Income from continuing operations | 61,571 | 55,228 | 146,043 | 139,327 | |||||||||||
Operating loss from discontinued operations | (788 | ) | (247 | ) | (1,432 | ) | (1,866 | ) | |||||||
(Benefit) taxes on loss from discontinued operations | (69 | ) | 24 | 180 | (345 | ) | |||||||||
Loss from discontinued operations | (719 | ) | (271 | ) | (1,612 | ) | (1,521 | ) | |||||||
Net income | 60,852 | 54,957 | 144,431 | 137,806 | |||||||||||
Less: Income from continuing operations attributable to noncontrolling interest | 28 | 126 | 692 | 765 | |||||||||||
Net income attributable to common shareholders | $ | 60,824 | $ | 54,831 | $ | 143,739 | $ | 137,041 | |||||||
Earnings per share available to common shareholders: | |||||||||||||||
Basic: | |||||||||||||||
Income from continuing operations | $ | 1.48 | $ | 1.33 | $ | 3.50 | $ | 3.35 | |||||||
Loss from discontinued operations | (0.02 | ) | (0.01 | ) | (0.04 | ) | (0.04 | ) | |||||||
Net income | $ | 1.46 | $ | 1.32 | $ | 3.46 | $ | 3.31 | |||||||
Diluted: | |||||||||||||||
Income from continuing operations | $ | 1.27 | $ | 1.18 | $ | 3.03 | $ | 3.00 | |||||||
Loss from discontinued operations | (0.02 | ) | — | (0.03 | ) | (0.04 | ) | ||||||||
Net income | $ | 1.25 | $ | 1.18 | $ | 3.00 | $ | 2.96 | |||||||
Dividends per share | $ | 0.34 | $ | 0.34 | $ | 1.02 | $ | 1.02 | |||||||
Weighted average common shares outstanding | |||||||||||||||
Basic | 41,597 | 41,399 | 41,542 | 41,347 | |||||||||||
Diluted | 48,532 | 46,628 | 47,969 | 46,256 | |||||||||||
Amounts attributable to common shareholders: | |||||||||||||||
Income from continuing operations, net of tax | $ | 61,543 | $ | 55,102 | $ | 145,351 | $ | 138,562 | |||||||
Loss from discontinued operations, net of tax | (719 | ) | (271 | ) | (1,612 | ) | (1,521 | ) | |||||||
Net income | $ | 60,824 | $ | 54,831 | $ | 143,739 | $ | 137,041 |
September 27, 2015 | December 31, 2014 | ||||||
(Dollars in thousands) | |||||||
ASSETS | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 276,463 | $ | 303,236 | |||
Accounts receivable, net | 272,996 | 273,704 | |||||
Inventories, net | 345,899 | 335,593 | |||||
Prepaid expenses and other current assets | 33,798 | 35,697 | |||||
Prepaid taxes | 43,966 | 40,256 | |||||
Deferred tax assets | 55,981 | 57,301 | |||||
Assets held for sale | 7,044 | 7,422 | |||||
Total current assets | 1,036,147 | 1,053,209 | |||||
Property, plant and equipment, net | 313,244 | 317,435 | |||||
Goodwill | 1,303,175 | 1,323,553 | |||||
Intangible assets, net | 1,192,364 | 1,216,720 | |||||
Investments in affiliates | 324 | 1,150 | |||||
Deferred tax assets | 940 | 1,178 | |||||
Other assets | 61,507 | 64,010 | |||||
Total assets | $ | 3,907,701 | $ | 3,977,255 | |||
LIABILITIES AND EQUITY | |||||||
Current liabilities | |||||||
Current borrowings | $ | 416,685 | $ | 368,401 | |||
Accounts payable | 67,906 | 64,100 | |||||
Accrued expenses | 67,027 | 72,383 | |||||
Current portion of contingent consideration | 545 | 11,276 | |||||
Payroll and benefit-related liabilities | 77,435 | 85,442 | |||||
Accrued interest | 7,490 | 9,169 | |||||
Income taxes payable | 9,728 | 13,768 | |||||
Other current liabilities | 10,655 | 10,360 | |||||
Total current liabilities | 657,471 | 634,899 | |||||
Long-term borrowings | 646,000 | 700,000 | |||||
Deferred tax liabilities | 406,101 | 451,541 | |||||
Pension and postretirement benefit liabilities | 148,514 | 167,241 | |||||
Noncurrent liability for uncertain tax provisions | 50,817 | 50,884 | |||||
Other liabilities | 57,737 | 58,991 | |||||
Total liabilities | 1,966,640 | 2,063,556 | |||||
Commitments and contingencies | |||||||
Total common shareholders' equity | 1,938,891 | 1,911,309 | |||||
Noncontrolling interest | 2,170 | 2,390 | |||||
Total equity | 1,941,061 | 1,913,699 | |||||
Total liabilities and equity | $ | 3,907,701 | $ | 3,977,255 |
Nine Months Ended | |||||||
September 27, 2015 | September 28, 2014 | ||||||
(Dollars in thousands) | |||||||
Cash Flows from Operating Activities of Continuing Operations | |||||||
Net income | $ | 144,431 | $ | 137,806 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Loss from discontinued operations | 1,612 | 1,521 | |||||
Depreciation expense | 34,035 | 37,409 | |||||
Amortization expense of intangible assets | 45,278 | 47,053 | |||||
Amortization expense of deferred financing costs and debt discount | 12,662 | 11,792 | |||||
Loss on extinguishment of debt | 10,454 | — | |||||
Gain on sale of assets | (408 | ) | — | ||||
Changes in contingent consideration | (3,260 | ) | (7,670 | ) | |||
Stock-based compensation | 10,379 | 9,125 | |||||
Deferred income taxes, net | (21,960 | ) | (2,808 | ) | |||
Other | (18,329 | ) | (4,310 | ) | |||
Changes in operating assets and liabilities, net of effects of acquisitions and disposals: | |||||||
Accounts receivable | (8,714 | ) | 2,442 | ||||
Inventories | (19,904 | ) | (23,084 | ) | |||
Prepaid expenses and other current assets | 1,636 | (4,087 | ) | ||||
Accounts payable and accrued expenses | (2,855 | ) | 14,258 | ||||
Income taxes receivable and payable, net | (8,297 | ) | (10,649 | ) | |||
Net cash provided by operating activities from continuing operations | 176,760 | 208,798 | |||||
Cash Flows from Investing Activities of Continuing Operations: | |||||||
Expenditures for property, plant and equipment | (45,566 | ) | (48,220 | ) | |||
Proceeds from sale of assets | 408 | 5,251 | |||||
Payments for businesses and intangibles acquired, net of cash acquired | (63,451 | ) | (28,535 | ) | |||
Investment in affiliates | — | (40 | ) | ||||
Net cash used in investing activities from continuing operations | (108,609 | ) | (71,544 | ) | |||
Cash Flows from Financing Activities of Continuing Operations: | |||||||
Proceeds from new borrowings | 288,100 | 250,000 | |||||
Reduction in borrowings | (303,627 | ) | (480,009 | ) | |||
Debt extinguishment, issuance and amendment fees | (9,017 | ) | (3,689 | ) | |||
Net proceeds from share based compensation plans and the related tax impacts | 4,815 | 2,936 | |||||
Payments to noncontrolling interest shareholders | (833 | ) | (1,094 | ) | |||
Payments for contingent consideration | (7,974 | ) | — | ||||
Dividends paid | (42,382 | ) | (42,174 | ) | |||
Net cash used in financing activities from continuing operations | (70,918 | ) | (274,030 | ) | |||
Cash Flows from Discontinued Operations: | |||||||
Net cash used in operating activities | (1,954 | ) | (1,946 | ) | |||
Net cash used in discontinued operations | (1,954 | ) | (1,946 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | (22,052 | ) | (6,880 | ) | |||
Net decrease in cash and cash equivalents | (26,773 | ) | (145,602 | ) | |||
Cash and cash equivalents at the beginning of the period | 303,236 | 431,984 | |||||
Cash and cash equivalents at the end of the period | $ | 276,463 | $ | 286,382 |
C\$RH!_!^,)E0#^#\6$L@:_P>C3*@8.G6YVRED#'\'6^M+(&/
MX.MSU*60 :<;ZTL@;'3K$L@:G3C>[*60,?P<'B4LAJ'\&VGQ2R!G^#C?!WRI
ME0#^#C?YWRIE0#^#C?7[TRH&K]/MC&=TR@CZRC%+DYV4Y2+D=Y_&.I"C*RUT
M8^J$1.,A,K&9"\ Y>))5>\3AZBL7,L-
M=/ ]K_G%7EL51T&D^(,>"B)<75R"+N'Q2J,%8KMY-E<#-XP$ SDZJ45$B3S8
M4D"\;=E# NUJ@L*\N A(E(=T*W-,A6L0;- *J#!&"A(O0C-0WVH"TCXON6-E
MBNW0YE?[5 *^_P", I_K#6?J0KYQ^(?;%X+[GM^$^S_ #^R/8Z\R=DP>B I?$=I=:) !D]M$5%/
MUHGZ!3J-I$0V6RS$.&M/@J V<< ^* 854A((PK(E#!T3I-@-RH1=ZD77121.
M#0?;A7N4LR0IJ=TU,7#8>M8I1S&:+RG,N(%-5PB62!I<.\>*XN*P4I:P.[A,
M7%.TCB5PN4T=6>UB,;L^"\U4ISINTD>GIU8S7FLE+1 7$#J5H3](W(>B4'4MWJF7*9L JH02G)K8\O7G>$4>T+_7&AHCRD@NWR%TJ< 0!@'N" .B R@,8R@#8>" ,A !QW@( TQ[D!E " Q@> 0!AO@$ 8;
MX! &Q[@@,'" P@#" ,( P@#" ,(#63XI5D"IZIE[.G>0<;+(C%(Y@;@]Q/I'
M'M6=+0I<7I)C)*W!/5585[ZEQMF>09.5IRW-A$K'W*I9FE?_ !14D7*#=GN;
M7'+CA;,-C7>Y'25'\XD+8LC&(.J#GXQ^5+(&S7/?T[W+)&Q!&V]U6:PLH2<'XS>55H_A
M>R>F;,Z[WEHRVB@]$ _SW]&^SJL4I=#/&FY:L\?:X\L/B%JJ61M+>S8*)VS8
M+9$V,@>N0Y<3[,+$Y,V%3BCGLG$[5M[J&R5&HKO5. P9)KA+OZNH'S)F9=17
M06J)[U
^2-\>1L2TX'=A>QHU%.":9Y2M!PDXLF>'UXND+IX*&YS4<
MTC20UA(:7#U#O/@L[9KI'3J:[7FX4D=%50T\];.
F<+R-:;C*QZ"%+/$I--J!E;*_FBP[*Q)IFS
M"BVQ#43Z"CLMQNTML@NCZ&!TS8)AMG&,]#N 3@]RNZF1.43?H83/5C"6ESSC
MQ/X7C7MBI]0V" MI:AI>*8.RZ+E/I =?=NNAAL6K6D:F-P#IS=N1,^1QIJ:
MDUQ74%93NY&0
S#@>F$*L<05T].W#7$@=RK8NC%5>JTQG!'RJ$B6WR(?SRNF<0
MYVQ\,I8C4I"T)*
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M